banner add

Pace of N.I.H. Funding Slows Further in Trump’s Second Year

The agency has approved far fewer new grants than it did in years past. A renewed effort to screen for disfavored terms and a loss of personnel are contributing.

from NYT > Health https://ift.tt/4ysTWmK
via IFTTT

No comments

F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy. from NYT > Health ...

Theme images by PLAINVIEW. Powered by Blogger.